Amneal’s generic Namenda XR introduced
Amneal’s generic Namenda XR (memantine hydrochloride extended release) capsules have launched in four dosage strengths. The drug is indicated for the treatment of moderate-to-sever dementia of the Alzheimer’s type.
Amneal’s generic Namenda XR will be available in 7-, 14-, 21- and 28-mg dosage strengths. The product had U.S. sales of roughly $929 million for the 12 months ended December 2017, according to IQVIA data.
Amneal’s generic Namenda XR will be available in 7-, 14-, 21- and 28-mg dosage strengths. The product had U.S. sales of roughly $929 million for the 12 months ended December 2017, according to IQVIA data.